Furthermore, measuring the enzymatic activity of SOD1 has proven beneficial in ALS drug trials and large-scale screenings for SOD1 mutations, providing a cost-effective alternative to next-generation sequencing [29]. Here, SOD1 is linked to amyotrophic lateral sclerosis.